This week, Teckro Program Director Brian Deighan joins the podcast to talk about how sponsors are using Teckro to better engage their research sites. Brian explains how innovative approaches in sponsor communication improve relationships with investigators and discusses how surveys are an underutilized tool for sponsors to understand their sites. “Email chains for information can get lost, items can get misunderstood, or things may be taken out of context. Teckro and our survey functionality allows for that direct line to sites and really hearing everything firsthand ..read more

This week, Lexitas Pharma Services' George Magrath joins the podcast to discuss his unique dual perspective on patient care as both a CEO and a physician. George shares how his double role gives him a better understanding of patient needs and helps Lexitas to stand out in a competitive market. “I love taking care of patients. It's really quite a privilege and quite an honor to be able to do that. I think it keeps me really grounded with the purpose of what I'm doing, which is trying to advance our care ..read more

In this episode, freelance medical translator Ana Sofia Correia joins us to discuss the need for translation in clinical trials. She explains the risks if clinical trial material is biased towards English speaking populations and the need for cultural sensitivity when translating content into local languages. Ana Sofia also reflects on the benefits AI could have on the industry and for translators. “While AI can be a powerful tool, it cannot replace human translators because there are still many aspects of translation that require human judgment and human expertise, such as the ability to unde ..read more

This episode we have something a little bit different as we talk with Karl McGrory, director of Europe at One Tree Planted. As an international nonprofit focused on reforestation, One Tree Planted has garnered widespread support from many sectors, including the pharmaceutical industry. Teckro has partnered with One Tree Planted and contributed to a project in Ireland, home to our HQ. Karl talks about Ireland’s significant deforestation over the centuries and upcoming projects they have around the world. “There's an old folklore that said a squirrel could travel from the south of Ireland to the ..read more

Have you ever had a chance encounter that changed the course of your life? That’s what happened to Danielle Mitchell, CEO of Black Women in Clinical Research. She discovered clinical research as a career path in a conversation at a pool party. After landing a clinical research coordinator role, she noticed the stark lack of diversity among staff. Since then, Danielle has been on a mission to educate and empower Black women to succeed in the industry. “A lot of times when I talk to my members, they will say that they stumbled upon clinical research and that's not the way that it should be. We s ..read more

This week Dr. Martine Dehlinger-Kremer, vice president, scientific affairs, pediatric subject matter expert at ICON, joins us for a deep dive into the inclusion of adolescents in clinical trials. Martine talks us through the considerations for including adolescents in adult clinical trials and how to overcome potential challenges. She also highlights disease areas where the inclusion of adolescents in adult trials has proved successful and why she is optimistic for the future. “Trial sponsors, investigators, regulators and ethics committees are encouraged to challenge research orthodoxy relate ..read more

This week we’re joined by former CRA Maria Milas and site advocate Silvina Baudino to discuss how to make investigator meetings (IMs) more exciting. Attending an IM can mean endless PowerPoint presentations and days of repetitive meetings – but there is a better way. Maria and Silvina explain how by recasting the agenda for greater interaction, attendees will be more engaged and retain more about the study.  “It was four intense days of meetings of trainings, of talks from 8 a.m. to 6 p.m. every single day. Now, how does this look? Well, PowerPoint after PowerPoint after more PowerPoint ..read more

A ..read more

A ..read more

A ..read more